Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NoNO Trial
NCT05213676Phase 4Recruiting
- Sponsor
- UTHealth Houston
- Start
- Nov 2025
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
A Phase 4 trial of nitric oxide in congenital diaphragmatic hernia (CDH), sponsored by UTHealth Houston. Started Nov 2025; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
congenital diaphragmatic hernia (CDH)
Beyond the preview
Go deeper on NCT05213676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213676.